I am a 67-year-old male with generally good vision. I have had a few floaters in my eyes over the years, but they have generally been small ...

FH is a genetic condition of very high cholesterol levels that presents a high risk for coronary artery disease.

I am a 69-year-old woman who was diagnosed with familial hypercholesterolemia (FH). I used statins for over a decade but developed vulvar lichen sclerosus (LS), which only went ...

Adding the PCSK9 inhibitor led to greater absolute reductions in CVD risk than in younger patients, with no signs of safety ...

non-intensive statin) analysis. Results: The data of 179 patients receiving statins and/or ezetimibe, 50 of which with evolucumab and 129 without, were analyzed. Evolocumab add-on therapy over six ...

In the one completed outcomes trial to date – the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial – in aortic stenosis patients, ezetimibe plus statin therapy did not reduce the ...

In SHARP, a randomized trial, investigators compared simvastatin plus ezetimibe with placebo. Of the 9270 patients (age, ≥40; mean age, 62; 63% men) with chronic kidney disease and no histories ...

Zocor (simvastatin) and Lipitor (atorvastatin) are both statin drugs, which are medications used to lower cholesterol levels in the blood. Statins primarily work by inhibiting the enzyme HMG-CoA ...

Patients were stratified by exposure to statin therapy, ezetimibe, and proprotein convertase subtilisin/kexin type 9 monoclonal antibodies (PCSK9i mAb). The study assessed LLT adherence (proportion of ...

alone or as a fixed-dose combination with ezetimibe, as preferred LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of cardiovascular disease with elevated ...